InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,477.90
(
0.16%
)
US TECH 100
19,129.60
(
-0.24%
)
Dow Jones
39,127.80
(
0.04%
)
Brent Oil
84.20
(
-0.33%
)
Bitcoin
60,943.75
(
0.22%
)
Post# of 252388
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 833
Posts 119931
Boards Moderated 17
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 244373

Tuesday, 02/21/2023 12:14:23 PM

Tuesday, February 21, 2023 12:14:23 PM

Post# of 252388
PFE’s maternal RSV vaccine has Aug 2023 PDUFA—(with_FDA_priority_review):

https://finance.yahoo.com/news/u-fda-accepts-biologics-license-114500315.html

In data reported in Nov 2022, one of two primary endpoints was met, but PFE said this was sufficient for FDA approval (#msg-170339033).

GSK terminated its own program for a maternal RSV vaccine, so PFE will have the only maternal RSV vaccine on the market if this BLA is approved.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up